*ST奧維(002231.SZ):預計半年度虧損6000萬元-9000萬元
格隆匯7月14日丨*ST奧維(002231.SZ)公佈,預計半年度虧損6,000-9,000萬元,扣非虧損6,250-9,250萬元。1. 由於子公司東和欣新材料產業(無錫)有限公司金屬製品業務處於停產、停工狀態,本報告期收入同比上期大幅下降。同時通信設備製造業務規模縮減,綜合導致本年虧損加大。2. 公司子公司東和欣新材料產業(無錫)有限公司的存貨由於江蘇大江金屬材料有限公司保管不善遭受損失,公司針對該存貨確認相應的資產損失。3. 資金佔用未按照約定時間還款,相關債權的回收仍存在風險性和不確定性,因此公司從謹慎性原則出發,審慎判斷逾期影響,計提信用減值損失。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.